✦ LIBER ✦

New therapies in sickle cell disease

✍ Scribed by Elliott Vichinsky

Book ID: 117281453
Publisher: The Lancet
Year: 2002
Tongue: English
Weight: 70 KB
Volume: 360
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(02)09776-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel Therapies Targeting the Endotheliu

Novel Therapies Targeting the Endothelium in Sickle Cell Disease

✍ Hoppe, Carolyn C. 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 348 KB

What's new in sickle cell disease?

✍ G.R. Serjeant 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Iron chelation therapy in sickle cell di

Iron chelation therapy in sickle cell disease

✍ Alan R Cohen; Marie B Martin 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Gene therapy for sickle-cell disease?

✍ Nathan Seppa 📂 Article 📅 2001 🏛 Society for Science & the Public 🌐 English ⚖ 185 KB

Severe Sickle Cell Disease—Pathophysiolo

Severe Sickle Cell Disease—Pathophysiology and Therapy

✍ George Buchanan; Elliott Vichinsky; Lakshmanan Krishnamurti; Shalini Shenoy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 89 KB

New concepts in assessing sickle cell di

New concepts in assessing sickle cell disease severity

✍ Schnog, John-John B.; Lard, Leroy R.; Rojer, Robert A.; Van der Dijs, Fey P. L.; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

Vasoocclusion leads to pain, chronic organ damage, and a decreased life expectancy in patients with sickle cell disease. Therapeutic options for sickle cell disease have usually been evaluated according to their capacity for reducing the frequency of vasoocclusive crises requiring clinical attention